Editorials |
From the Dorrance H. Hamilton Research Laboratories, Division of Endocrinology, Diabetes, and Metabolic Diseases, Department of Medicine (K.J.W.), Jefferson Medical College of Thomas Jefferson University, Philadelphia, Penn; and the Departments of Medicine, Anatomy & Cell Biology, and Physiology & Cellular Biophysics (I.T.), Columbia University, New York, NY.
Correspondence to Kevin Jon Williams, Department of Medicine, Thomas Jefferson University, 1020 Locust Street, Suite 348, Philadelphia, PA 19107. E-mail K_Williams{at}mail.jci.tju.edu
Subendothelial retention of apoB-lipoproteins is the key initiating event in atherosclerosis, provoking a cascade of pathogenic responses. Dissection of the molecular participants provides fresh insight into how this major killer might be reversed. Efflux of harmful lipids derived from retained lipoproteins may be crucial in promoting beneficial remodeling of lesions.
This article has been cited by other articles:
![]() |
H. N. Ginsberg and E. A. Fisher The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism J. Lipid Res., April 1, 2009; 50(Supplement): S162 - S166. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Quinn, M. Henriques, T. Parker, A. S. Slutsky, and H. Zhang Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1817 - H1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Parasassi, M. De Spirito, G. Mei, R. Brunelli, G. Greco, L. Lenzi, G. Maulucci, E. Nicolai, M. Papi, G. Arcovito, et al. Low density lipoprotein misfolding and amyloidogenesis FASEB J, July 1, 2008; 22(7): 2350 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pan, V. Maitin, S. Parathath, U. Andreo, S. X. Lin, C. St. Germain, Z. Yao, F. R. Maxfield, K. J. Williams, and E. A. Fisher Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: A pathway for late-stage quality control PNAS, April 15, 2008; 105(15): 5862 - 5867. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Tabas, K. J. Williams, and J. Boren Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications Circulation, October 16, 2007; 116(16): 1832 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Liu, M. P. Reilly, P. Casasanto, S. E. McKenzie, and K. J. Williams Cholesterol Enrichment of Human Monocyte/Macrophages Induces Surface Exposure of Phosphatidylserine and the Release of Biologically-Active Tissue Factor-Positive Microvesicles Arterioscler. Thromb. Vasc. Biol., February 1, 2007; 27(2): 430 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Houard, A. Leclercq, V. Fontaine, M. Coutard, J.-L. Martin-Ventura, B. Ho-Tin-Noe, Z. Touat, O. Meilhac, and J.-B. Michel Retention and Activation of Blood-Borne Proteases in the Arterial Wall: Implications for Atherothrombosis J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A3 - A9. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rosengren, H. Peilot, M. Umaerus, A.-C. Jonsson-Rylander, L. Mattsson-Hulten, C. Hallberg, P. Cronet, M. Rodriguez-Lee, and E. Hurt-Camejo Secretory Phospholipase A2 Group V: Lesion Distribution, Activation by Arterial Proteoglycans, and Induction in Aorta by a Western Diet Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1579 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Williams and I. Tabas Letter by Williams and Tabas Regarding Article "Atherosclerosis 2005: Recent Discoveries and Novel Hypotheses" Circulation, May 30, 2006; 113(21): e782 - e782. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |